Literatur
Bretschneider HJ: Myocardial protection. Thorac Cardiovasc Surg 1980;28:295–302.
Braimbridge, M, Chayen J, Bitensky L, Hearse D, Jynge P, Cankovic-Darracott S: Cokl cardioplegia or continous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg 1977;74:900–906.
Bodenhamer R, DeBoer L, Geffin G, O’Keefe D, Aretz T, Haas G, Daggett W: Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution. J Thorac Cardiovase Surg 1983;85:769–780.
Bical O, Gerharth M, Gaillard D, Comas J, Landais P, Fischer M, Trivin F, Vanetti A: Comparison of different types of cardioplegia and reperfusion on myocardial metabolism and free radical activity. Circulation 1991;84 (suppl III): 375–379.
Iverson L, Young N, Ennix C, Ecker R: Myocardial protection: A comparison of cold blood and cold crystalloid cardioplegia. J Thorac Cardiovasc Surg 1984;87:509–516.
Axford-Gatley R, Wilson G, Feindel C: Comparison of blood-based and asanguineous cardioplegic solutions administered at 4 °C. An ultrastructural morphometric study in the dog. J Thorac Cardiovasc Surg 1990;100:400–409.
Barner H: Blood Cardioplegia: A review and comparison with crystalloid cardioplegia. Ann Thorac Surg 1991;52:1354–1367.
Buckberg GD: Antegrade/retrograde blood cordioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Card Surg 1989;4:216–238.
Grote J: Gewebsatmung, in Schmidt R, Threws G. Physiologie des Menschen. 24. Aufl. Berlin-Heidelerg-New York-London-Paris-Tokyo-Hong Kong-Barcelona, 1990.
Acar C, Partington M, Buckberg G: Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: Detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion. J Thorac Cardiovasc Surg 1991;101:294–302.
Li GC, Vasques LA, Gallagher KP, Lucchesi BR: Myocardial protection with preconditioning. Circulation 1990;82:609–619.
Grover GJ, Sleph PG, Dzwonczyk S: Role of myocardial ATPsensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine Al-receptors. Circulation 1992;86:1310–1316.
Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK: Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Circulation 1990;82:2044–2051.
Murry C, Richard V, Riemer K, Jennings R: Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circulation Res 1990;66:913–931.
Knight C, Purchell H, Fox K: Potassium channel openers: clinical applications in ischemic heart disease-overview of clinical efficacy of nicorandil. Cardiovasc Drugs Ther 1995;9 (suppl II): 229–236.
Braunwald E, Kloner RA: The stunned myocardium: Prolonged postischemic ventricular dysfunction. Circulation 1982;66:1146–1149.
Bolli R: Mechanisms of myocardial stunning. Circulation 1990;82:723–738.
Opie LH: Postischemic stunning-the case for calcium as the ultimate culprit. in Opie LH (eds). Sturning, hibernation, and calcium in myocardial ischemia and reperfusion. 1st ed. Massachusetts. Kluwer, 1992, pp 88–97.
Rosenkranz E, Okamota F, Buckberg G, Robertson J, Vinthen-Johnsen, Bugyi H: Safty of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury. J Thorac Cardiovasc Surg 1989;91:428–435.
Seitelberger R, Zwölfer W, Huber S, Schwarzacher S, Binder T, Peschl F, Spatt J, Holzinger C, Podesser B, Buxbaum P, Weber H, Wolner E: Nifedipine reduces the incidences of myocardial infarction and transient ischemia im patients undergoing coronary bypass grafting. Circulation 1991;83:460–468.
Podesser B, Schwarzacher S, Zwölfer W, Wolner E, Seitelberger R: Comparison of perioperative myocardial protection with nifedipine versus nifedipine and metoprolol in patients undergoing elective aortocoronary bypass surgery. J Thorac Cardiovasc Surg 1995;110:1461–1469.
Ferrari R, Visioli O: Protective effects of calcium antagonists against ischemia and reperfusion damage. Drugs 1991;42:14–27.
Grinstead WC, Young JB: The myocardial renin-angiotensin system: existence. importance and clinical implication. Am Heart J 1991;123:1039–1045.
Linz W, Schölkens BA: Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1992;20:83–90.
Podesser B, Zegner M, Koci G, Hallström S, Wollenek G: Ramiprilat during reperfusion. J Mol Cell Cardiol 1995;27:A212.
Mills S: Risk factors for cerebral injury and cardiac surgery. Ann Thorac Surg 1995;59:1296–1299.
Hall TS: The pathophysiology of cardiopulmonary bypass. The risks and benefits of hemodilution. Chest 1995;107:1125–1133.
Experimentelle Untersuchungen mit Ca2+-Antagonisten und β-Rezeptorblocker zur Operation am schlagenden Herz. Noch nicht veröffentlichte Daten der Autoren.
Buckberg GD: Update on current techniques of myocardial protection. Ann Thorac Surg 1995;60:805–814.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Podesser, B., Wolner, E. Intraoperative Myokard-protektion—Standards und Perspektiven. Acta Chir Austriaca 28, 326–327 (1996). https://doi.org/10.1007/BF02616275
Issue Date:
DOI: https://doi.org/10.1007/BF02616275